GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mcl-1 in complex with a bim competitive inhibitor

Analyse Crystal structure of mcl-1 in complex with a bim competitive inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6B4L
Type
protein
Length
300 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Induced myeloid leukemia cell differentiation protein mcl- 1
UniProt
Q07820
Ligands
CJY
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 80% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BInduced myeloid leukemia cell differentiation protein mcl- 1protein15080% helix, 0% strandQ07820

Ligands and binding sites

  • CJY · 3-{3-[(naphthalen-1-yl)oxy]propyl}-1H-indole-2-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11670.660.8518CJY
21630.630.8417CJY
34080.620.7733empty

Interfaces

1 interface between chains.

  • A–B · 581 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 6B4L · Crystal structure of MCL-1 in complex with a BIM competitive inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.